TotalMarketCap

Dyadic International

DYAINasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$13.650 M

$0.34 -7.09%

Close of 6 Nov 2026

As of 6 Nov 2026, Dyadic International (DYAI) has a market capitalization of $13.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$3.09M

#3339 by revenue

Earnings

-$7.36M

Loss-making

Shares outstanding

36,438,703

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #144Atyr PharmaATYR$15.4M
  2. #145ScilexSCLX$14.3M
  3. #146Dyadic InternationalDYAI$13.6M
  4. #147BioCardiaBCDA$13.4M
  5. #148TScan TherapeuticsTCRX$11.5M

What if Dyadic International were worth as much as…

Open the what-if tool →

Gold $28.2T

$704,799.38

Per share 2,068,680× higher

Bitcoin $1.53T

$38,135.47

Per share 111,933× higher

Apple $5.02T

$125,195.18

Per share 367,465× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Dyadic International are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.